{
  "report_rows": [
    {
      "kpi": "FQ4'26 Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$8.4B vs. cons ~$8.3B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FQ4'26 Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$35.00 vs. cons ~$34.00",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FQ4'26 Non-GAAP Gross Margin",
      "prediction": "BEAT",
      "answer": "pred ~81.5% vs. cons ~80.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FQ1'27 Revenue guide (midpoint)",
      "prediction": "BETTER",
      "answer": "guide ~$9.0B vs. cons ~$8.7B (FQ1'27)",
      "confidence": "LOW"
    },
    {
      "kpi": "FQ1'27 Gross Margin guide",
      "prediction": "BETTER",
      "answer": "guide ~81% vs. cons ~79% (FQ1'27)",
      "confidence": "LOW"
    },
    {
      "kpi": "FQ1'27 Non-GAAP EPS guide",
      "prediction": "BETTER",
      "answer": "guide ~$38 vs. cons ~$36 (FQ1'27)",
      "confidence": "LOW"
    },
    {
      "kpi": "NBM contracted-bit coverage of FY2027 (durability signal)",
      "prediction": "BETTER",
      "answer": "guide ~50% of FY27 bits vs. prior >33% (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 7.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": 2.0,
  "day5_path": "FADE",
  "day5_rationale": "Likely beat-and-raise on record revenue/margins triggers an oversold relief pop off the ~55% July drawdown (stock already bounced from ~$1,016 to ~$1,428 into the print). But consensus already embeds a beat-and-raise, and the market's core worry is out-period ASP/margin normalization (CXMT/China NAND oversupply, peak-cycle 2028). Even a strong near-term guide leaves 2H-CY26/FY28 estimates exposed to implicit cuts, so the initial spike fades as the cyclical-peak narrative and profit-taking reassert; \u00b125% implied vol makes direction low-conviction.",
  "day5_confidence": "LOW"
}